Odisha had to cover 1,10,387 beneficiaries in the first week of public immunisation drive till Friday. The state covered 1,13,623 beneficiaries – an achievement of 102.9% of the planned beneficiaries. Odisha is one of the 11 states to receive both the vaccines Covaxin and Covishield.
A fast-spreading variant of the coronavirus that causes COVID-19 has been found in at least 22 states, and people are wondering: How do I protect myself now? We saw what the new variant, known as B.1.1.7, can do as it spread quickly through southeastern England in December, causing case numbers to spike and triggering stricter lockdown measures. The new variant has been estimated to be 50% more easily transmitted than common variants, though it appears to affect people's health in the same way.
The government this month gave emergency-use approval to the vaccine, developed by Bharat Biotech International Ltd and state-run Indian Council of Medical Research, and another licensed from Oxford University and AstraZeneca PLC that is being manufactured by the Serum Institute of India.
Pointing out that the pandemic exposed the "shortcomings" in the India healthcare system, they have urged Finance Minister Nirmala Sitharaman to hike the allocation in the Budget to be presented in Parliament on February 1.
"We manufacture, distribute and market personal hygiene products.. We believe there is tremendous (growth) opportunity as income rises and awareness increases. Paree sanitary pads is already a Rs 100 crore brand. With Super Cute, we are looking to add another Rs 50 crore," Soothe Healthcare Chief Executive Officer and Founder Sahil Dharia told .
As on January 24, till 8 am, nearly 16 lakh (15,82,201) beneficiaries have received Covid-19 vaccination. In a span of 24 hours, close to 2 lakh (1,91,609) people were vaccinated across 3,512 sessions. A total of 27,920 sessions have been conducted so far, the ministry said.
According to the scientists, including those from Rockefeller University in the US, the study provides the "strongest evidence yet" that the immune system "remembers" the virus and, remarkably, continues to improve the quality of antibodies even after the infection has waned.
Dr AP Nirmal Raj pointed out he took the Covid vaccine on January 17. “I’m taking anti-diabetic, cholesterol drugs and have undergone angioplasty earlier. People with comorbidities must not fear the vaccine,” he said.
What should come out in public in clear terms is that both the vaccines are proving to be safe. Even though the efficacy data is not out yet, safety data is out and both vaccines are found to be safe. Now whether it will protect 80% of the population or more or less, we don’t know, says Dr Jameel.
Despite doubts, vaccine hesitancy and teething tech issues, India has managed to inoculate more than 1.2 million frontline workers in the first week of the Covid immunisation campaign, perhaps the fastest rollout anywhere in the world. The government plans to launch a drive to address concerns and scale-up daily numbers. India aims to vaccinate 300 million healthcare and frontline workers in this initial phase. ET reports on the first week of the campaign:
"Our results suggest that the COVID-19 virus may awaken an antibody response that existed in humans prior to our current pandemic, meaning that we might already have some degree of pre-existing immunity to this virus," said John Altin, a co-author of the study from the Translational Genomics Research Institute (TGen) in the US.